Search Within

Harper Hubbeling

Formats
  1. Meeting Abstract (36)
  2. Journal Article (9)
  3. Research Letter (1)
Groups
  1. GME, Radiation Oncology (46)
  2. Graduate Medical Education (46)
  3. Radiation Oncology, Department of (44)
  4. Survivorship Research (40)
  5. Department of Medicine (32)
  6. Hematologic Malignancies, Division of (27)

More Groups

People
  1. Brandon Imber (42)
  2. Joachim Yahalom (36)
  3. Carla Hajj (33)
  4. Kathryn Tringale (28)
  5. Beatrice Fregonese (22)
  6. Michael Scordo (19)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (19)
  4. 2022 (18)
  5. 2021 (4)
  6. 2019 (1)
Publications
  1. Blood (13)
  2. International Journal of Radiation Oncology, Biology, Physics (8)
  3. Hematological Oncology (7)
  4. Radiotherapy and Oncology (4)
  5. Clinical Cancer Research (3)
  6. Transplantation and Cellular Therapy (3)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (15)
  3. Wiley Blackwell (7)
  4. American Association for Cancer Research (3)
  5. American Medical Association (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (46)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Characterization of central nervous system clinico-genomic outcomes in ALK-positive non-small cell lung cancer patients with brain metastases treated with alectinib
    Journal Article

    Miao, E.; Eichholz, J. E.; Lebow, E. S.; Flynn, J.; Zhang, Z.; Walch, H.; Hubbeling, H.; Beal, K.; Moss, N. S.; Yu, K. K.; more...
    Lung Cancer (2023)

    Fulltext@MSK | Save
  • Outcomes with local therapy and tyrosine kinase inhibition in patients with ALK/ROS1/RET-rearranged lung cancers
    Journal Article

    Hubbeling, H.; Choudhury, N.; Flynn, J.; Zhang, Z. G.; Falcon, C.; Rusch, V. W.; Park, B. J.; Ziv, E.; Shaverdian, N.; Gelblum, D. Y.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Primary hepatic lymphoma: Role of low-dose radiotherapy at a single institution with genetic characterization and paired literature review
    Meeting Abstract

    Ma, J.; Daou, R.; Eid, J. B.; Lee, J.; Fregonese, B.; El-Khoury, J.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K. R.; Lebow, E. S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Safety and efficacy of splenic irradiation for non-Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Imber, B. S.; Wijetunga, N. A.; Tringale, K. R.; Hajj, C.; Yahalom, J.
    Blood (2022)

    Fulltext@MSK | Save
  • Radiotherapy for secondary CNS lymphoma: Patterns of utilization and clinical outcomes
    Meeting Abstract

    Cederquist, G. Y.; Tringale, K. R.; Hajj, C.; Hubbeling, H.; Fregonese, B.; Lee, J.; Scordo, M.; Grommes, C.; Yahalom, J.; Imber, B. S.
    Blood (2022)

    Fulltext@MSK | Save
  • Genetic Alterations of CREBBP are associated with radiosensitivity in follicular lymphoma
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E. S.; Lee, J.; Fregonese, B.; Tringale, K. R.; Hubbeling, H.; Sarkar, R.; Ma, J.; Seshan, V.; Joffe, E.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • "Big Boom" (4 Gy x 1) radiation treatment (RT) versus "Big Boom" (2 Gy x 2) for non-Hodgkin lymphoma (NHL)
    Meeting Abstract

    Hajj, C.; Lebow, E. S.; Lee, J.; Fregonese, B.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K. R.; Freret, M. E.; Imber, B. S.; Yahalom, J.
    Blood (2022)

    Fulltext@MSK | Save
  • Initial treatment response is prognostic and predictive of relapse patterns: Outcomes of >500 patients treated for primary CNS lymphoma
    Meeting Abstract

    Tringale, K. R.; Yahalom, J.; Scordo, M.; Cederquist, G. Y.; Vachha, B.; Schaff, L.; Hajj, C.; Hubbeling, H.; Zhang, Z.; White, C.; more...
    Blood (2022)

    Fulltext@MSK | Save